Delivery Order SPE2DB22D2206-SPE2DB24FDS44
Award Date 10/14/23
Potential Completion Date 10/16/23
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $12,109.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Neulasta 6 mg/0.6 ml syringes on September 26, 2025, with completion scheduled for September 29, 2025. This non-set-aside contract represents a routine pharmaceutical procurement from the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $20,817 delivery order to Amerisourcebergen Drug Corporation for 4561866354 NEULASTA 6 MG/0.6 ML SYRINGE. The firm fixed price order is for the delivery of 0.6mL syringes of NEULASTA, a medication used to treat chemotherapy-induced neutropenia. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three day period concluding on August 21, 2023. No subcontractors or set aside designations were identified. This order...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $22,645.20 firm fixed price delivery order by the Defense Logistics Agency to supply 4562086202 NEULASTA ONPRO 6 MG/0.6 ML KIT 0.6ML. Performance will take place in Conshohocken, Pennsylvania over one day from September 7-8, 2023. The Defense Logistics Agency utilizes contracts like this to efficiently acquire necessary pharmaceutical and medical supplies for the U.S. Department of Defense and...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $12,425.82 firm fixed price delivery order by the Defense Logistics Agency to supply NEULASTA ONPRO 6 MG/0.6 ML kits. Performance will take place in Conshohocken, Pennsylvania over a period of one day, from August 8 to August 9, 2023. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, responsible for worldwide logistics support in both peacetime and...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,215,932 units of the pharmaceutical product NEULASTA 6 MG/0.6 ML SYRINGE 0.6ML. The order, with a potential value of $8,897.37, has a completion date of January 3, 2024. The award was made on January 2, 2024, and no set-aside designations were used. Amerisourcebergen Drug Corp, through its Corporate Office division, is an...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty-two thousand seven hundred thirteen dollars and twelve cents ($32,713.12) to Amerisourcebergen Drug Corporation for the supply of NEULASTA ONPRO 6 MG/0.6 ML KIT medication. Performance will take place in Conshohocken, Pennsylvania under a one day period from July 24, 2023 through July 25, 2023. The award was made using the Defense Logistics Agency's indefinite-delivery/indefinite-quantity pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,530.76 to AmerisourceBergen Drug Corp for Neulasta Onpro 6 mg/0.6 ml kits on September 9, 2025, with completion scheduled for September 10, 2025. The award utilized firm fixed pricing with no set-aside designation, indicating competitive selection among eligible contractors. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,337.32 to AmerisourceBergen Drug Corp for Neulasta OnPro 6 mg/0.6 mL kits on September 12, 2025, with completion expected by September 15, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug...
- This delivery order, awarded to AmerisourceBergen Drug Corp on August 25, 2025, procures Neulasta OnPro 6 mg/0.6 mL kits valued at $14,023.92 through a firm fixed-price contract with the Defense Logistics Agency (DLA). The contract requires completion by August 26, 2025, and represents a non-competitive, non-set-aside award for pharmaceutical supply to support federal medical needs. Neulasta is a specialty medication used for chemotherapy-related side effects, and this procurement leverages...
- This federal contract award, with ID SPE2DB22D1106|SPE2DB25FEHG7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,011.96 firm fixed-price delivery order is for the supply of NEULASTA ONPRO 6 MG/0.6 ML KIT 0.6ML, a prescription medication, with an ultimate completion date of April 11, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FDS44Delivery Order
Amerisourcebergen Drug Corp has been awarded a $3,705.11 firm fixed price delivery order for NEULASTA 6 MG/0.6 ML SYRINGE 0.6ML by the Defense Logistics Agency. The delivery order was awarded on October 14, 2023 under an unspecified contract vehicle and has an anticipated completion date of October 16, 2023. Place of performance will be in Conshohocken, Pennsylvania. No set-aside designation was applied to this award to supply the requested pharmaceutical product in support of Defense Logistics Agency programs.
Generated 1/13/24, 9:26 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 10/14/23 |